PTK2 and lung carcinoma: In lung cancer, integrin β4/PXN/FAK complex mediates cisplatin resistance through regulating ubiquitin specific peptidase 1 (USP1) and voltage-dependent anion channel 1 (VDAC1), which are associated with mitochondrial function and maintaining genomic stability [111].